PRKACG antibody
Quick Overview for PRKACG antibody (ABIN969365)
Target
See all PRKACG AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Purpose
- PRKACG Antibody
-
Purification
- Ascitic fluid
-
Immunogen
- Purified recombinant fragment of human PRKACG expressed in E. Coli.
-
Isotype
- IgG1
-
-
-
-
Application Notes
-
ELISA: 1/10000
FCM: 1/200 - 1/400
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Ascitic fluid containing 0.03 % sodium azide.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
-
-
-
: "The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on ..." in: The Journal of clinical endocrinology and metabolism, Vol. 94, Issue 7, pp. 2406-13, (2009) (PubMed).
-
: "The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on ..." in: The Journal of clinical endocrinology and metabolism, Vol. 94, Issue 7, pp. 2406-13, (2009) (PubMed).
-
- PRKACG (Protein Kinase, CAMP-Dependent, Catalytic, gamma (PRKACG))
-
Alternative Name
- PRKACG
-
Background
- Cyclic AMP-dependent protein kinase (PKA) consists of two catalytic subunits and a regulatory subunit dimer. This gene encodes the gamma form of its catalytic subunit. The gene is intronless and is thought to be a retrotransposon derived from the gene for the alpha form of the PKA catalytic subunit.
-
Molecular Weight
- 40.4 kDa
-
Gene ID
- 5568
-
UniProt
- P22612
-
Pathways
- AMPK Signaling, Hedgehog Signaling, Thyroid Hormone Synthesis, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Lipid Metabolism
Target
-